Cargando…
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
OBJECTIVES: To evaluate the effect of pioglitazone in people with insulin resistance, pre-diabetes and type 2 diabetes. DESIGN AND SETTING: Systematic review and meta-analysis of randomised, controlled trials. DATA SOURCES: Literature searches were performed across PubMed, EMBASE, MEDLINE and Cochra...
Autores principales: | Liao, Hung-Wei, Saver, Jeffrey L, Wu, Yi-Ling, Chen, Tso-Hsiao, Lee, Meng, Ovbiagele, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223642/ https://www.ncbi.nlm.nih.gov/pubmed/28057658 http://dx.doi.org/10.1136/bmjopen-2016-013927 |
Ejemplares similares
-
Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
por: Liao, Hung‐Wei, et al.
Publicado: (2018) -
Prevalence of diabetes and pre-diabetes in Bangladesh: a systematic review and meta-analysis
por: Akhtar, Sohail, et al.
Publicado: (2020) -
Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol
por: Wang, Xianzhe, et al.
Publicado: (2019) -
Effect of pre-diabetes on future risk of stroke: meta-analysis
por: Lee, Meng, et al.
Publicado: (2012) -
Prevalence of type 2 diabetes and pre-diabetes in Sri Lanka: a systematic review and meta-analysis
por: Akhtar, Sohail, et al.
Publicado: (2023)